Biomarkers and Immunotherapeutic Targets in Glioblastoma.
Sign Up to like & getrecommendations! Published in 2017 at "World neurosurgery"
DOI: 10.1016/j.wneu.2017.03.011
Abstract: Glioblastoma (GBM) is an aggressive central nervous system cancer with poor prognosis despite maximal therapy. The recent advent of immunotherapy holds great promise for improving GBM survival and has already made great strides toward changing… read more here.
Keywords: targets glioblastoma; immunotherapeutic targets; medicine; biomarkers immunotherapeutic ... See more keywords